First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.

Détails

ID Serval
serval:BIB_09A338EFDE78
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma.
Périodique
Journal of Clinical Oncology
Auteur(s)
Beck M.N., Balmer A., Dessing C., Pica A., Munier F.
ISSN
0732-183X
Statut éditorial
Publié
Date de publication
2000
Peer-reviewed
Oui
Volume
18
Numéro
15
Pages
2881-2887
Langue
anglais
Résumé
PURPOSE: To evaluate the efficacy of first-line chemotherapy (CT) in preventing external-beam radiotherapy (EBR) and/or enucleation in patients with retinoblastoma (Rbl). PATIENTS AND METHODS: Twenty-four patients with newly diagnosed unilateral or bilateral Rbl received CT associated with local treatment (LT). Two to five courses of etoposide and carboplatin were administered at 3- to 4-week intervals, depending on tumor response, and were completed each time by LT. RESULTS: Tumor response was observed in all eyes. Twenty-one of 24 patients showed a complete response (CR) that persisted at a median follow-up (FU) of 31 months (range, 4 to 41 months). Among the three patients who relapsed, two were lost to FU and one died of progressive disease. CR was achieved by CT and LT alone in 15 (71.4%) of 21 patients with less advanced disease (groups I to III). Six other patients with advanced disease (groups IV and V) experienced treatment failure and needed salvage treatment by EBR and/or enucleation. The difference between the two patient groups with regard to disease stage was statistically significant (P <.0001). EBR could be avoided in 13 (68.4%) of 19 patients, who presented with groups I to III (15 eyes) and group V (one eye) disease, whereas enucleation could be avoided in only two (40%) of five. CONCLUSION: CT combined with intensive LT is effective in patients with groups I to III Rbl, permitting the avoidance of EBR in the majority of these young children and, thus, reducing the risk of long-term sequelae. This is in contrast with the disappointing results for patients with groups IV and V Rbl, in whom EBR and/or enucleation was needed.
Mots-clé
Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carboplatin/administration & dosage, Child, Child, Preschool, Combined Modality Therapy, Disease Progression, Etoposide/administration & dosage, Eye Enucleation, Female, Humans, Male, Retinal Neoplasms/drug therapy, Retinal Neoplasms/radiotherapy, Retinoblastoma/drug therapy, Retinoblastoma/radiotherapy, Treatment Outcome
Pubmed
Web of science
Création de la notice
20/03/2008 9:34
Dernière modification de la notice
20/08/2019 12:31
Données d'usage